Roivant Sciences Ltd.

The estimated Net Worth of Roivant Sciences Ltd. is at least $1066 Million dollars dollars as of 05/27/2022. Roivant Sciences Ltd. is the 10% Owner of Sio Gene Therapies Inc. Roivant Sciences Ltd. owns over 18,577,380 shares of Sio Gene Therapies Inc stock worth over $6 Million dollars . Roivant Sciences Ltd. is the 10% Owner of Myovant Sciences Ltd. Roivant Sciences Ltd. owns over 45,008,604 shares of Myovant Sciences Ltd stock worth over $488 Million dollars . Roivant Sciences Ltd. is the 10% Owner of Urovant Sciences Ltd. Roivant Sciences Ltd. owns over 22,860,013 shares of Urovant Sciences Ltd stock worth over $371 Million dollars . Roivant Sciences Ltd. is the 10% Owner of Immunovant Inc. Roivant Sciences Ltd. owns over 47,593,419 shares of Immunovant Inc stock worth over $201 Million dollars .

Roivant Sciences Ltd. mailing address: CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11

Insider Roles

Name	Transaction Date	Position
Immunovant Inc	2020-09-17	10 percent owner
Sio Gene Therapies Inc	2018-06-05	10 percent owner
Myovant Sciences Ltd	2016-10-26	10 percent owner
Urovant Sciences Ltd	2019-12-27	10 percent owner
Arbutus Biopharma Corp	2021-10-18	10 percent owner
Immunovant Inc	2019-12-18	10 percent owner

EMBED

SAVE

Roivant Sciences Ltd. trading performance

Average Relative Return

9.54%

Average relative return per transaction

Outperforming Transactions

71%

10 out of 14 outperforming transactions.

Each transaction is measured over a period and compared to .

Roivant Sciences Ltd. trading performance analysis

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Relative Return(%)	0.7	-2.21	25.65	9.54	-52.78
Relative Return to S&P 500(%)	-1.2	-4.11	18.42	2.61	-62.59

Roivant Sciences Ltd. trading transactions

Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
IMVT	Immunovant Inc	$4.22	Roivant Sciences Ltd.	10% Owner	2020-09-04	Buy	380,000	0.80%	$33	$12,540,000	47,593,419	-87.21%	-	0	At Loss	491.19
IMVT	Immunovant Inc	$4.22	Roivant Sciences Ltd.	10% Owner	2020-04-16	Buy	1,034,483	2.77%	$14.50	$15,000,000	38,439,450	-70.90%	-	0	At Loss	491.19
SIOX	Sio Gene Therapies Inc	$0.31	Roivant Sciences Ltd.	10% Owner	2020-02-24	Buy	5,333,333	40.27%	$3.75	$20,000,000	18,577,380	-91.60%	-	0	At Loss	23.21
MYOV	Myovant Sciences Ltd	$10.84	Roivant Sciences Ltd.	10% Owner	2019-12-17	Buy	245,000	0.55%	$15.38	$3,768,100	45,008,604	-29.52%	-	0	At Loss	1,033.40
MYOV	Myovant Sciences Ltd	$10.84	Roivant Sciences Ltd.	10% Owner	2019-12-04	Buy	254,193	0.57%	$18.03	$4,583,100	44,763,604	-39.88%	-	0	At Loss	1,033.40
MYOV	Myovant Sciences Ltd	$10.84	Roivant Sciences Ltd.	10% Owner	2019-11-25	Buy	3,500,000	8.53%	$15	$52,500,000	44,509,411	-27.73%	-	0	At Loss	1,033.40
MYOV	Myovant Sciences Ltd	$10.84	Roivant Sciences Ltd.	10% Owner	2019-11-21	Buy	243,812	0.60%	$12.39	$3,020,830	41,009,411	-12.51%	-	0	At Loss	1,033.40
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-06-19	Buy	18,204	0.08%	$8.32	$151,457	22,860,013	95.19%	-	0	At Loss	531.75
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-06-14	Buy	22,011	0.10%	$8.06	$177,409	22,841,809	101.49%	-	0	At Loss	531.75
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-06-11	Buy	21,338	0.09%	$8.31	$177,319	22,819,798	95.43%	-	0	At Loss	531.75
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-06-06	Buy	21,122	0.09%	$7.86	$166,019	22,798,460	106.62%	-	0	At Loss	531.75
MYOV	Myovant Sciences Ltd	$10.84	Roivant Sciences Ltd.	10% Owner	2019-06-04	Buy	2,424,242	6.32%	$8.25	$20,000,000	40,765,599	31.39%	-	0	At Loss	1,033.40
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-06-03	Buy	17,746	0.08%	$7.83	$138,951	22,777,338	107.41%	-	0	At Loss	531.75
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-05-29	Buy	14,485	0.06%	$7.63	$110,521	22,759,592	112.84%	-	0	At Loss	531.75
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-05-23	Buy	19,830	0.09%	$8.22	$163,003	22,745,107	97.57%	-	0	At Loss	531.75
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2019-05-20	Buy	21,608	0.10%	$7.54	$162,924	22,725,277	115.38%	-	0	At Loss	531.75
SIOX	Sio Gene Therapies Inc	$0.31	Roivant Sciences Ltd.	10% Owner	2019-03-18	Buy	6,666,667	6.71%	$1.50	$10,000,000	13,244,047.63	-79.01%	-	0	At Loss	23.21
SIOX	Sio Gene Therapies Inc	$0.31	Roivant Sciences Ltd.	10% Owner	2018-12-18	Buy	10,000,000	11.20%	$1	$10,000,000	12,410,714.25	-68.51%	-	0	At Loss	23.21
UROV	Urovant Sciences Ltd	$16.24	Roivant Sciences Ltd.	10% Owner	2018-10-01	Buy	2,678,571	13.38%	$14	$37,500,000	22,703,669	16%	-	0	At Loss	531.75
SIOX	Sio Gene Therapies Inc	$0.31	Roivant Sciences Ltd.	10% Owner	2018-06-05	Buy	14,285,714	19.05%	$1.75	$25,000,000	11,160,714.25	-82.01%	-	0	At Loss	23.21
MYOV	Myovant Sciences Ltd	$10.84	Roivant Sciences Ltd.	10% Owner	2018-04-02	Buy	1,110,015	2.98%	$20.27	$22,500,000	38,341,357	-46.52%	-	0	At Loss	1,033.40

Total 21

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roivant Sciences Ltd. personal network

Name	Position	Linked company

Get Premium to unlock powerful stock data

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.